Table 5.
Group | p Value | OR (Lower CI-Upper CI) |
---|---|---|
RAAS-inhibitors usage | 0.09 | 2.62 (0.88–8.53) |
Immunosppressants usage | 0.16 | 0.32 (0.06–1.59) |
Vitamin D supplements usage | 0.13 | 0.35 (0.07–1.24) |
EPO usage | 0.55 | 1.62 (0.29–8.13) |
Age | 0.11 | 0.96 (0.90–1.01) |
Sex | 0.02 (*) | 6.21 (1.53–42.19) |
Univariate logistic regression analysis of factors potentially influencing SARS-CoV-2 vaccine response. OR, odds ratio; CI, confidence interval; RAAS, renin-angiotensin-aldosteron system; EPO, erythropoietin; p values < 0.05 were considered significant; (*), significant value.